{"prompt": "['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', 'Tertiary', 'To assess the use of EXACT-PRO for determining the', 'end date of AECOPD.', 'To evaluate the load of bacterial and viral pathogens in', 'stable COPD and during AECOPD.', 'To collect biological specimens for future respiratory', 'disease-related testing:', '-', 'Aliquots of sputum samples for assay development', 'and microbiome analysis at stable visits and during', 'exacerbation.', '-', 'Blood sampling for potential', 'identification/quantification of biomarkers at Visit 1', 'and Visit 3.', 'Rationale for the', 'Because the infectious aetiology of AECOPD has been', 'study', 'suggested to vary according to geographical region, the', 'primary purpose of this study (which will be conducted in', 'several countries in Asia Pacific) is to evaluate the occurrence', 'of potential bacterial and viral pathogens in the sputum of', 'stable COPD patients and at the time of AECOPD. Given the', 'increasing and projected burden of COPD in the Asia Pacific', 'region, this study will also evaluate the frequency, severity', 'and duration of AECOPD, as well as the impact of AECOPD', 'on health-related quality of life (HRQOL), healthcare', 'utilisation and lung function.', 'In addition, both PCR and bacteriological methods will be', 'used for characterisation (quantification in some cases) of', 'bacteria in sputum. To date, identification of bacteria and', 'assessment of bacterial load is done in the vast majority of', 'cases by culture. However, the few studies that have', 'compared culture with PCR demonstrated that PCR is more', 'discriminatory at detecting typical airway bacteria [Curran,', '2007; Singh 2014]. Moreover, in a multi-centre study, PCR', 'has the advantage that it can be performed on stored sputum', 'samples, and can therefore be done centrally, whereas culture', 'has to be performed on fresh sputum samples, which can lead', 'to variable results due to variability in testing methods', 'between laboratories.', '19-OCT-2018', '9', '75661ebdab2e949f7a1f1bc2071b9dec72acecct']['CONFIDENTIAL', '201112 (EPI-NTHI-001 BOD APA)', 'Protocol Amendment 3 Final', 'Study design', 'Type of design: Prospective, epidemiological,', 'interventional, multi-country, cohort study.', 'Study population: A stable cohort of approximately 200', 'moderate to very severe COPD patients with at least 1', 'documented moderate or severe AECOPD in the year', 'before enrolment.', 'Type of study: self-contained.', 'Data collection: Electronic Case Report Form (eCRF)', 'and electronic diary cards.', 'Primary completion Date: Visit 3 (Month 12). Refer to', 'glossary of terms for the definition of PCD.', 'End of Study (EoS): Last testing results released of', 'samples collected at Visit 3.', 'Duration of the study: The study will last approximately', '1 year for each subject.', 'Note: Screening visit should ideally occur not more than', '6 weeks before visit 1.', 'Epoch 001: Prospective data collection starting at', 'Screening Visit (Pre-Month 0) and ending at Visit 3', '(Month 12).', 'Synopsis Table 1', 'Study groups and epochs foreseen in the study', 'Number of', 'Epoch', 'Study Groups', 'Age (Min/Max)', 'subjects', 'Epoch 001', 'Prospective', 'Approx 200', '> 40 years', 'X', 'Discussion of study', 'The primary objective of this study is to prospectively', 'design', 'investigate the prevalence and distribution of bacteria and', 'viruses isolated from sputum samples from moderate to very', 'severe COPD patients and at the time of AECOPD, in Asian', 'populations. In order to increase the chance that the patients', 'will exacerbate during the study, only patients with a', 'documented history of at least 1 moderate or severe AECOPD', 'in the previous year will be recruited, as this is known to be', 'the best predictor of AECOPD [Hurst, 2010]. Therefore, this', 'study will permit an estimation of incidence of AECOPD in a', 'COPD population at increased risk of exacerbation. It will not', 'provide a true population-based incidence of AECOPD.', 'In order to study factors affecting disease progression in Asia', 'Pacific, prospective data from a relatively large cohort of', 'COPD patients is essential. The use of electronic Diary Cards', 'to detect changes in the respiratory symptoms that define an', 'AECOPD, the standardised questionnaires and spirometry', '19-OCT-2018', '10', '75661ebdab2e949f7a1f1bc2071b9dec72aceccf']\n\n###\n\n", "completion": "END"}